Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of NanoSALV Catalytic Compared to a Standard Topical Care Pathway in Sports-Related Skin Lesions

NCT07807904 is registered in ClinicalTrials.gov with Shahab Alizadeh as lead sponsor.

NCT NCT07807904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07807904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of NanoSALV Catalytic Compared to a Standard Topical Care Pathway in Sports-Related Skin Lesions
Lead sponsor
Shahab Alizadeh
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
May 31, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blister, blister of foot